These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22434258)

  • 1. Stability of amorphous pharmaceutical solids: crystal growth mechanisms and effect of polymer additives.
    Sun Y; Zhu L; Wu T; Cai T; Gunn EM; Yu L
    AAPS J; 2012 Sep; 14(3):380-8. PubMed ID: 22434258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallization of organic glasses: effects of polymer additives on bulk and surface crystal growth in amorphous nifedipine.
    Cai T; Zhu L; Yu L
    Pharm Res; 2011 Oct; 28(10):2458-66. PubMed ID: 21638137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface mobility of molecular glasses and its importance in physical stability.
    Yu L
    Adv Drug Deliv Rev; 2016 May; 100():3-9. PubMed ID: 26774328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical stability of amorphous pharmaceutical solids: Nucleation, crystal growth, phase separation and effects of the polymers.
    Shi Q; Li F; Yeh S; Wang Y; Xin J
    Int J Pharm; 2020 Nov; 590():119925. PubMed ID: 33011255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-concentration polymers inhibit and accelerate crystal growth in organic glasses in correlation with segmental mobility.
    Powell CT; Cai T; Hasebe M; Gunn EM; Gao P; Zhang G; Gong Y; Yu L
    J Phys Chem B; 2013 Sep; 117(35):10334-41. PubMed ID: 23909486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast crystal growth of amorphous nimesulide: implication of surface effects.
    Shi Q; Wang Y; Xu J; Liu Z; Chin CY
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2022 Feb; 78(Pt 1):33-39. PubMed ID: 35129118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Polymers on Cocrystal Growth in a Drug-Drug Coamorphous System: Relations between Glass-to-Crystal Growth and Surface-Enhanced Crystal Growth.
    Luo M; Chen A; Huang C; Guo M; Cai T
    Mol Pharm; 2024 Jul; 21(7):3591-3602. PubMed ID: 38818946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of Solid-State Crystal Growth in Molecular Glasses by Fluidity.
    Musumeci D; Powell CT; Ediger MD; Yu L
    J Phys Chem Lett; 2014 May; 5(10):1705-10. PubMed ID: 26270370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface-enhanced crystallization of amorphous nifedipine.
    Zhu L; Wong L; Yu L
    Mol Pharm; 2008; 5(6):921-6. PubMed ID: 19434917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Physical Stability of Amorphous Drug Formulations via Dry Polymer Coating.
    Capece M; Davé R
    J Pharm Sci; 2015 Jun; 104(6):2076-2084. PubMed ID: 25902736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Polymer Enrichment at the Crystal-Liquid Interface on Crystallization Kinetics of Amorphous Solid Dispersions.
    Zhang J; Shi Q; Tao J; Peng Y; Cai T
    Mol Pharm; 2019 Mar; 16(3):1385-1396. PubMed ID: 30716277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Polymer Hydrophobicity on the Stability of Amorphous Solid Dispersions and Supersaturated Solutions of a Hydrophobic Pharmaceutical.
    Frank DS; Matzger AJ
    Mol Pharm; 2019 Feb; 16(2):682-688. PubMed ID: 30645134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface Stabilization and Dissolution Rate Improvement of Amorphous Compacts with Thin Polymer Coatings: Can We Have It All?
    Novakovic D; Peltonen L; Isomäki A; Fraser-Miller SJ; Nielsen LH; Laaksonen T; Strachan CJ
    Mol Pharm; 2020 Apr; 17(4):1248-1260. PubMed ID: 32027513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting Surface Crystallization and Improving Dissolution of Amorphous Loratadine by Dextran Sulfate Nanocoating.
    Zeng A; Yao X; Gui Y; Li Y; Jones KJ; Yu L
    J Pharm Sci; 2019 Jul; 108(7):2391-2396. PubMed ID: 30831122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactants Accelerate Crystallization of Amorphous Nifedipine by Similar Enhancement of Nucleation and Growth Independent of Hydrophilic-Lipophilic Balance.
    Yao X; Benson EG; Gui Y; Stelzer T; Zhang GGZ; Yu L
    Mol Pharm; 2022 Jul; 19(7):2343-2350. PubMed ID: 35477294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What We Need to Know about Solid-State Isothermal Crystallization of Organic Molecules from the Amorphous State below the Glass Transition Temperature.
    Newman A; Zografi G
    Mol Pharm; 2020 Jun; 17(6):1761-1777. PubMed ID: 32275832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of atomic force microscopy for determining crystal growth rates of nifedipine at the surface of amorphous solids with and without polymers.
    Miyazaki T; Aso Y; Kawanishi T
    J Pharm Sci; 2011 Oct; 100(10):4413-20. PubMed ID: 21541940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationships Between Structure and the Properties of Amorphous Solids of Pharmaceutical Interest.
    Zografi G; Newman A
    J Pharm Sci; 2017 Jan; 106(1):5-27. PubMed ID: 27372552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast surface crystallization of amorphous griseofulvin below T g.
    Zhu L; Jona J; Nagapudi K; Wu T
    Pharm Res; 2010 Aug; 27(8):1558-67. PubMed ID: 20414704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.